Market Access/ Views & Analysis/ Views and analysis The US biosimilar market: Predictions for 2021 mike.hammerton@pharmaphorum.com 2021, AmerisourceBergen, biosimilar, reimbursement, US market 0 Comment It has been five years since the first biosimilar launched in the United States market—marking the first steps Share X The US biosimilar market: Predictions for 2021 https://pharmaphorum.com/views-and-analysis/biosimilar-market-predictions-2021/
2021, AmerisourceBergen, biosimilar, reimbursement, US market
0 Comment
